Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05177822Phase 2Active Not Recruiting
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
Heart Failure
PrincipalinvestigatorStart date: 2022-05-24
NCT03797001Phase 2Completed
Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2
Heart Failure, SystolicInflammation
PrincipalinvestigatorStart date: 2019-01-04
NCT01936896Phase 1/2Completed
Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction
Acute Myocardial Infarction
Principalinvestigator
NCT02173548Phase 2Completed
Interleukin-1 Blockade in HF With Preserved EF
Heart Failure With Normal Ejection Fraction
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Antonio Abbate, MD, PhD

Virginia Commonwealth University

Similar
12 trials

Shared therapeutic areas:

Acute Myocardial InfarctionHeart FailureHeart Failure, Systolic+2 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)Virginia Commonwealth University
Collaborated on 2 trials
Similarity Score58%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

HypertensionInflammation

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score10%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Heart FailureHypertension
Similarity Score10%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score5%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Inflammation
Similarity Score5%

Neha sharma, PhD

Warwick Research Services

Related
11 trials

Shared therapeutic areas:

Hypertension
Similarity Score5%

Mitesh Patel, MD, MBA, MS

University of Pennsylvania

Related
15 trials

Shared therapeutic areas:

Hypertension

Worked with same sponsors:

National Institute on Aging (NIA)
Similarity Score5%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Heart Failure
Similarity Score5%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

Hypertension
Similarity Score5%

Glen P Kenny, PhD

University of Ottawa

Related
18 trials

Shared therapeutic areas:

Hypertension
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05177822Phase 2PrincipalInvestigator

Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure

Heart Failure
Active Not Recruiting
NCT03797001Phase 2PrincipalInvestigator

Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2

Heart Failure, SystolicInflammation
Completed
NCT03323840Not ApplicablePrincipalInvestigator

Pilot for a Community Pharmacy Service Model: Impact of a Pharmacist Monitored Patient Blood Pressure Readings

Hypertension
Completed
NCT01936896Phase 1/2PrincipalInvestigator

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

Acute Myocardial Infarction
Completed
NCT02173548Phase 2PrincipalInvestigator

Interleukin-1 Blockade in HF With Preserved EF

Heart Failure With Normal Ejection Fraction
Completed

All 5 trials loaded